Although the majority of studies characterizing IL-18 and IL-18BP in IBD have been mostly descriptive in nature, they have laid the foundation that underscores the importance of the balance between IL-18 and IL-18BP in gut health and the pathogenesis of chronic intestinal inflammation, particularly in patients with CD. This evidence concerns the gene IL18 and irritable bowel syndrome.